| RS149266855 |
PRKCG
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS149266909 |
FTCD
|
Health Risk |
Pathogenic/Likely pathogenic |
Glutamate formiminotransferase deficiency, Glutamate formiminotransferase deficiency |
| RS149267056 |
KIF1B
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS149267939 |
COL7A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Epidermolysis bullosa dystrophica, Epidermolysis bullosa dystrophica inversa |
| RS149268172 |
CCBE1
|
Health Risk |
Pathogenic |
— |
| RS149268308 |
EMC1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS149268737 |
LRPPRC
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital lactic acidosis, Saguenay-Lac-Saint-Jean type |
| RS149270152 |
CLPX
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS149270486 |
CAST
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS149271265 |
SPAG1
|
Health Risk |
Conflicting classifications of pathogenicity |
Primary ciliary dyskinesia 28, Primary ciliary dyskinesia |
| RS149271416 |
NDUFS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Mitochondrial complex I deficiency, nuclear type 5 |
| RS149272010 |
SYNE1
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive ataxia, Beauce type |
| RS149272208 |
KCNQ3
|
Health Risk |
Conflicting classifications of pathogenicity |
Benign neonatal seizures, Seizures |
| RS149273387 |
APOB
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypercholesterolemia, autosomal dominant |
| RS149273459 |
POT1
|
Health Risk |
Conflicting classifications of pathogenicity |
Tumor predisposition syndrome 3, Hereditary cancer-predisposing syndrome |
| RS149274011 |
ODAD2
|
Health Risk |
Likely pathogenic |
Primary ciliary dyskinesia 23, Primary ciliary dyskinesia 23 |
| RS149274310 |
EPCAM
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary nonpolyposis colorectal neoplasms, Ovarian cancer |
| RS149276791 |
SETX
|
Health Risk |
Conflicting classifications of pathogenicity |
Amyotrophic lateral sclerosis type 4, Spinocerebellar ataxia |
| RS149276836 |
LAMP2
|
Health Risk |
Conflicting classifications of pathogenicity |
Danon disease, Cardiomyopathy |
| RS149277003 |
FANCA
|
Health Risk |
Pathogenic/Likely pathogenic |
Fanconi anemia, Fanconi anemia complementation group A |
| RS149277592 |
SDHAF2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary pheochromocytoma and paraganglioma, Hereditary cancer-predisposing syndrome |
| RS149278000 |
MBD5
|
Health Risk |
Conflicting classifications of pathogenicity |
Intellectual disability, autosomal dominant 1 |
| RS149278134 |
SACS
|
Health Risk |
Conflicting classifications of pathogenicity |
Charlevoix-Saguenay spastic ataxia, Spastic paraplegia |
| RS149278155 |
FN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS149278319 |
DNAJB6
|
Health Risk |
Pathogenic |
Autosomal dominant limb-girdle muscular dystrophy type 1D (DNAJB6), Autosomal dominant limb-girdle muscular dystrophy type 1D (DNAJB6) |
| RS149278759 |
TSC1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Tuberous sclerosis 1 |
| RS149279510 |
ABCC8
|
Health Risk |
Conflicting classifications of pathogenicity |
Transitory neonatal diabetes mellitus, Maturity-onset diabetes of the young |
| RS149279535 |
BLK
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS149280976 |
CBS
|
Health Risk |
Conflicting classifications of pathogenicity |
Classic homocystinuria, Familial thoracic aortic aneurysm and aortic dissection |
| RS149281325 |
SLC25A24
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS149282954 |
RP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinitis pigmentosa, Retinitis pigmentosa 1 |
| RS149286529 |
ATP1A2
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial hemiplegic migraine, Inborn genetic diseases |
| RS149287302 |
PEX2
|
Health Risk |
Pathogenic |
Peroxisome biogenesis disorder 5A (Zellweger), Peroxisome biogenesis disorder 5B |
| RS149287595 |
PCED1A
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS149287760 |
CARD14
|
Health Risk |
Conflicting classifications of pathogenicity |
Pityriasis rubra pilaris, Psoriasis 2 |
| RS149287861 |
SKIC3
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS149288077 |
SYNJ1
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy, 53 |
| RS149288103 |
NCSTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS149288560 |
PITX2
|
Health Risk |
Conflicting classifications of pathogenicity |
Anterior segment dysgenesis 4, Axenfeld-Rieger syndrome type 1 |
| RS149290718 |
SACS
|
Health Risk |
Conflicting classifications of pathogenicity |
Spastic paraplegia, Charlevoix-Saguenay spastic ataxia |
| RS149291477 |
IMPG2
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinitis pigmentosa, Retinitis pigmentosa |
| RS149291812 |
RUSC2
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS149291867 |
HLCS
|
Health Risk |
Conflicting classifications of pathogenicity |
Holocarboxylase synthetase deficiency, Inborn genetic diseases |
| RS149292107 |
CHRNA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Lethal multiple pterygium syndrome, Lethal multiple pterygium syndrome |
| RS149292242 |
ANK2
|
Health Risk |
Conflicting classifications of pathogenicity |
Long QT syndrome, Cardiac arrhythmia |
| RS149293164 |
CEP57
|
Health Risk |
Conflicting classifications of pathogenicity |
Mosaic variegated aneuploidy syndrome 2, Inborn genetic diseases |
| RS149293297 |
PCCA
|
Health Risk |
Conflicting classifications of pathogenicity |
Propionic acidemia, Propionic acidemia |
| RS149293844 |
PDE6B
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinitis pigmentosa, Congenital stationary night blindness autosomal dominant 2 |
| RS149294320 |
HTRA1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS149294914 |
RORB
|
Health Risk |
Pathogenic |
Neurodevelopmental delay, Neurodevelopmental delay |
| RS149295542 |
FAT1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS149296029 |
STIL
|
Health Risk |
Conflicting classifications of pathogenicity |
Microcephaly 7, primary |
| RS149296057 |
NCAPD2
|
Health Risk |
Conflicting classifications of pathogenicity |
Microcephaly 21, primary |
| RS149296177 |
MYO7A
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal dominant nonsyndromic hearing loss 11, Autosomal recessive nonsyndromic hearing loss 2 |
| RS149296223 |
POLE
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Polymerase proofreading-related adenomatous polyposis |
| RS149296737 |
SYNE2
|
Health Risk |
Conflicting classifications of pathogenicity |
Emery-Dreifuss muscular dystrophy 5, autosomal dominant |
| RS149297443 |
POMK
|
Health Risk |
Conflicting classifications of pathogenicity |
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a |
| RS149298083 |
RNF168
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS149300055 |
DYNC1H1
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease axonal type 2O, Autosomal dominant cerebellar ataxia |
| RS149300444 |
MTRR
|
Health Risk |
Conflicting classifications of pathogenicity |
Methylcobalamin deficiency type cblE, Disorders of Intracellular Cobalamin Metabolism |
| RS149300669 |
SHROOM4
|
Health Risk |
Conflicting classifications of pathogenicity |
Intellectual disability, See cases |
| RS149301001 |
COL1A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Osteogenesis imperfecta type I, Ehlers-Danlos syndrome |
| RS149302199 |
KANSL1
|
Health Risk |
Conflicting classifications of pathogenicity |
Koolen-de Vries syndrome, Koolen-de Vries syndrome |
| RS149303254 |
ASPM
|
Health Risk |
Conflicting classifications of pathogenicity |
Microcephaly 5, primary |
| RS149303333 |
POU4F3
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal dominant nonsyndromic hearing loss 15, POU4F3-related disorder |
| RS149304336 |
EDEM3
|
Health Risk |
Pathogenic |
— |
| RS149304901 |
USH2A
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinitis pigmentosa, Usher syndrome type 2A |
| RS149305108 |
LAMA2
|
Health Risk |
Conflicting classifications of pathogenicity |
LAMA2-related muscular dystrophy, LAMA2-related muscular dystrophy |
| RS149305351 |
COL5A2
|
Health Risk |
Conflicting classifications of pathogenicity |
Ehlers-Danlos syndrome, classic type |
| RS149306655 |
USH2A
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS149306841 |
APOB
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypercholesterolemia, autosomal dominant |
| RS149307620 |
NOTCH3
|
Health Risk |
Conflicting classifications of pathogenicity |
Cerebral arteriopathy, autosomal dominant |
| RS149307907 |
HUWE1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS149308824 |
ACADM
|
Health Risk |
Conflicting classifications of pathogenicity |
Medium-chain acyl-coenzyme A dehydrogenase deficiency, Inborn genetic diseases |
| RS149308952 |
CLN8
|
Health Risk |
Conflicting classifications of pathogenicity |
Neuronal ceroid lipofuscinosis 8, Neuronal ceroid lipofuscinosis |
| RS149308960 |
ESR1
|
Health Risk |
Conflicting classifications of pathogenicity |
ESR1-related disorder, ESR1-related disorder |
| RS149309725 |
L1CAM
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Spastic paraplegia |
| RS149310631 |
ARG1
|
Health Risk |
Pathogenic/Likely pathogenic |
Arginase deficiency, Arginase deficiency |
| RS149310653 |
PKHD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive polycystic kidney disease, PKHD1-related disorder |
| RS149311534 |
MBD4
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS149311926 |
PCSK9
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypercholesterolemia, familial |
| RS149313666 |
CPLANE1
|
Health Risk |
Conflicting classifications of pathogenicity |
Joubert syndrome 17, Clear cell carcinoma of kidney |
| RS149314387 |
FAM161A
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinitis pigmentosa, Retinitis pigmentosa |
| RS149315236 |
SCN1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Severe myoclonic epilepsy in infancy, Generalized epilepsy with febrile seizures plus |
| RS149315279 |
INVS
|
Health Risk |
Conflicting classifications of pathogenicity |
Nephronophthisis, INVS-related disorder |
| RS149316006 |
SPTB
|
Health Risk |
Conflicting classifications of pathogenicity |
SPTB-related disorder, SPTB-related disorder |
| RS149316157 |
JAK3
|
Health Risk |
Pathogenic |
T-B+ severe combined immunodeficiency due to JAK3 deficiency, T-B+ severe combined immunodeficiency due to JAK3 deficiency |
| RS149316679 |
CLCN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Batten-Turner congenital myopathy, Congenital myotonia |
| RS149317524 |
TNFRSF11A
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS149317715 |
SPTBN2
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS149317945 |
SYNE1
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive ataxia, Beauce type |
| RS149318176 |
VPS13B
|
Health Risk |
Conflicting classifications of pathogenicity |
Cohen syndrome, Inborn genetic diseases |
| RS149319186 |
ABCC9
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1O, Cardiovascular phenotype |
| RS149319607 |
HSPG2
|
Health Risk |
Conflicting classifications of pathogenicity |
Schwartz-Jampel syndrome, Lethal Kniest-like syndrome |
| RS149320135 |
PTS
|
Health Risk |
Conflicting classifications of pathogenicity |
6-Pyruvoyl-tetrahydrobiopterin synthase deficiency, 6-Pyruvoyl-tetrahydrobiopterin synthase deficiency |
| RS149321481 |
EGFR
|
Health Risk |
Conflicting classifications of pathogenicity |
EGFR-related lung cancer, Inflammatory skin and bowel disease |
| RS149322865 |
MAN1B1
|
Health Risk |
Conflicting classifications of pathogenicity |
Rafiq syndrome, Inborn genetic diseases |
| RS149323475 |
APOB
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypercholesterolemia, autosomal dominant |
| RS149323691 |
NDUFS4
|
Health Risk |
Conflicting classifications of pathogenicity |
Leigh syndrome, Mitochondrial complex I deficiency |
| RS149324120 |
KCNQ3
|
Health Risk |
Conflicting classifications of pathogenicity |
Benign neonatal seizures, Inborn genetic diseases |